Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Bright Prospects: 3 Energy Stocks Eyeing a Massive Rally in July

Here are three energy stocks with a bright future that could see upside momentum in the months to come for patient investors.

Why META Stock Is Still a Tech Gem for Long-Term Investors

Here's why Meta Platforms shouldn't be overlooked by long-term investors seeking value in the mega-cap tech space.

COIN Stock Alert: What to Know as the Supreme Court Sides With Coinbase

Coinbase has made some headway in the legal system and shares of COIN stock are rising as a result in today's session.

Big Returns Ahead: 3 High-Yield Dividend Stocks for H2 2023

Here are three high-yield dividend stocks long-term investors might want to consider adding in the second half of the year.

Why Is Carvana (CVNA) Stock Down 14% Today?

Today's move in shares of CVNA stock may be surprising to some investors, but the race for market share is on, and its peers are winning.

Beyond Tesla: 3 EV Stocks Offering Greater Long-Term Returns

Three EV stocks investors shouldn't sleep on, and none of these companies happen to be named Tesla.

Post-Nvidia Boom: 3 Potential Windfall Stocks Ready to Surge

The search is on for high-growth stocks to buy, but there are plenty of options to consider beyond Nvidia right now.

Why Is Sotera Health (SHC) Stock Up 20% Today?

Shares of SHC stock are surging higher today, as Sotera Health announced a settlement for ongoing claims against its subsidiary.

TRxADE Health (MEDS) Stock Soars 60% on Reverse Split

Investors in TRxADE Health are seeing a lot of green on the screen today, as MEDS stock surges more than 50% following a split.

Invest Like a Billionaire: 3 Long-Term Stocks Warren Buffett Loves

Warren Buffett is undoubtedly one of the greatest investors of all time, due in large part to the performance of these three companies.